Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $444.7M
Liabilities Breakdown FY2021
Total Liabilities: $25.2M
Asset Breakdown
Total Assets: $444.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $39.1M | 8.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.6M | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $27.2M | 6.1% |
| Other Assets | $374.8M | 84.3% |
Liabilities Breakdown
Total Liabilities: $25.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 4.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $24.0M | 95.1% |